VITAGEL SURGICAL HEMOSTAT

Absorbable Collagen Hemostatic Agent With Thrombin

FDA Premarket Approval P990030

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for costasis(r) surgical hemostat and dynastat(tm) surgical hemostat. This device is indicated for use in surgical procedures (other than in neurosurgical, ophthalmic, and urological) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.

DeviceVITAGEL SURGICAL HEMOSTAT
Classification NameAbsorbable Collagen Hemostatic Agent With Thrombin
Generic NameAbsorbable Collagen Hemostatic Agent With Thrombin
ApplicantANGIOTECH MEDICAL DEVICE TECHNOLOGIES
Date Received1999-06-07
Decision Date2000-06-13
Notice Date2000-07-12
PMAP990030
SupplementS
Product CodePMX
Docket Number00M-1368
Advisory CommitteeGeneral & Plastic Surgery
Expedited ReviewNo
Combination Product Yes
Applicant Address ANGIOTECH MEDICAL DEVICE TECHNOLOGIES 3600 S.w 47th Avenue gainesville, FL 32608
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P990030Original Filing
S005 2004-08-23 Normal 180 Day Track No User Fee
S004 2002-04-30 Normal 180 Day Track
S003 2001-12-27 Normal 180 Day Track
S002 2001-11-20 Special (immediate Track)
S001 2000-10-18 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.